NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
15.49
-0.60 (-3.73%)
Feb 5, 2026, 4:00 PM EST - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $515.94 million as of February 5, 2026. Its market cap has increased by 23.12% in one year.
Market Cap
515.94M
Enterprise Value
527.10M
1-Year Change
23.12%
Ranking
Category
Stock Price
$15.49
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $515.94M, an increase of 31.19%. That is a compound annual growth rate of 5.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 515.94M | 0.32% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avanos Medical | 649.40M |
| Tactile Systems Technology | 620.48M |
| Cytek Biosciences | 603.52M |
| Beta Bionics | 602.70M |
| Varex Imaging | 581.84M |
| Perspective Therapeutics | 561.60M |
| Bioventus | 557.24M |
| Pacific Biosciences of California | 546.45M |